Response to : 'Severe COVID-19 associated pneumonia in 3 patients with systemic sclerosis treated with rituximab' by Avouac et al
| Errataetall: |
CommentOn: Ann Rheum Dis. 2021 Jan;80(1):e10. - PMID 32312768 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:80 |
|---|---|
| Enthalten in: |
Annals of the rheumatic diseases - 80(2021), 3 vom: 23. März, Seite e38 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Guilpain, Philippe [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
4F4X42SYQ6 |
|---|
| Anmerkungen: |
Date Completed 27.06.2022 Date Revised 01.07.2022 published: Print-Electronic CommentOn: Ann Rheum Dis. 2021 Jan;80(1):e10. - PMID 32312768 Citation Status MEDLINE |
|---|
| doi: |
10.1136/annrheumdis-2020-217955 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM310833884 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM310833884 | ||
| 003 | DE-627 | ||
| 005 | 20231225140942.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1136/annrheumdis-2020-217955 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1036.xml |
| 035 | |a (DE-627)NLM310833884 | ||
| 035 | |a (NLM)32503848 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Guilpain, Philippe |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Response to |b 'Severe COVID-19 associated pneumonia in 3 patients with systemic sclerosis treated with rituximab' by Avouac et al |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 27.06.2022 | ||
| 500 | |a Date Revised 01.07.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: Ann Rheum Dis. 2021 Jan;80(1):e10. - PMID 32312768 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 4 | |a B-Lymphocytes | |
| 650 | 4 | |a autoantibodies | |
| 650 | 4 | |a rituximab | |
| 650 | 7 | |a Immunologic Factors |2 NLM | |
| 650 | 7 | |a Rituximab |2 NLM | |
| 650 | 7 | |a 4F4X42SYQ6 |2 NLM | |
| 700 | 1 | |a Le Bihan, Clément |e verfasserin |4 aut | |
| 700 | 1 | |a Foulongne, Vincent |e verfasserin |4 aut | |
| 700 | 1 | |a Taourel, Patrice |e verfasserin |4 aut | |
| 700 | 1 | |a Pansu, Nathalie |e verfasserin |4 aut | |
| 700 | 1 | |a Maria, Alexandre Thibault Jacques |e verfasserin |4 aut | |
| 700 | 1 | |a Jung, Boris |e verfasserin |4 aut | |
| 700 | 1 | |a Larcher, Romaric |e verfasserin |4 aut | |
| 700 | 1 | |a Klouche, Kada |e verfasserin |4 aut | |
| 700 | 1 | |a Le Moing, Vincent |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of the rheumatic diseases |d 1939 |g 80(2021), 3 vom: 23. März, Seite e38 |w (DE-627)NLM000174114 |x 1468-2060 |7 nnns |
| 773 | 1 | 8 | |g volume:80 |g year:2021 |g number:3 |g day:23 |g month:03 |g pages:e38 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1136/annrheumdis-2020-217955 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 80 |j 2021 |e 3 |b 23 |c 03 |h e38 | ||